Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CTLA4 anticorps

Cet anticorps Lapin Monoclonal détecte spécifiquement CTLA4 dans IHC. Il présente une réactivité avec des échantillons de Humain.
N° du produit ABIN7863998
687,58 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour Recombinant CTLA4 anticorps (ABIN7863998)

Antigène

Voir toutes CTLA4 Anticorps
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 194
  • 119
  • 55
  • 15
  • 10
  • 2
Humain

Hôte

  • 107
  • 107
  • 23
  • 22
  • 10
  • 3
  • 2
  • 1
  • 1
Lapin

Clonalité

  • 203
  • 70
  • 3
Monoclonal

Conjugué

  • 138
  • 22
  • 21
  • 20
  • 15
  • 7
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp CTLA4 est non-conjugé

Application

  • 105
  • 87
  • 67
  • 51
  • 36
  • 29
  • 28
  • 16
  • 13
  • 10
  • 7
  • 6
  • 5
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

CTLA4-6867R
  • Fonction

    Recombinant CTLA4 / CD152 (Negative Regulator of T-Cells) Antibody

    Specificité

    Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) is a member of the CD28 superfamily and is a negative regulator of T cell-mediated immune responses. CTLA-4 expression is induced on the surface of T cells after CD28 binding and activation, and is constitutively expressed on T-regulatory cells, acting as an immune checkpoint inhibitor, downregulating T cell activity. CTLA-4 primarily inactivates T-cell activity by competing with the CD28 costimulatory molecule. CD28 and CTLA-4 share the identical ligands of CD80 and CD86 on antigenpresenting cells, and thus CTLA-4 competes with CD28 function in T-cell survival, proliferation, and recruitment. In particular, CTLA-4 down-modulates CD4+ helper T-cell activity and enhances Treg immunosuppressive functions. CTLA-4 has been shown to play a role in human diseases. CTLA-4 acts as a physiological brake on the activated immune system in order to maintain immune homeostasis. Several suppressive mechanisms for T-cell functions have been attributed to CTLA-4.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant fragment of human CTLA4 (exact sequence is proprietary)

    Isotype

    IgG, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))

    Autre désignation

    CTLA4

    Sujet

    ALPS5, CD152, Celiac disease 3 (CELIAC3), Cytotoxic T-lymphocyte-associated antigen 4 (CTLA4), GRD4, GSE, ICOS, Insulin-dependent Diabetes Mellitus 12 (IDDM12)

    Jurkat or Raji cells. Lymph node or tonsil.

    Poids moléculaire

    30-43kDa

    ID gène

    1493, 247824

    UniProt

    P16410

    Pathways

    Cancer Immune Checkpoints
Vous êtes ici:
Chat with us!